Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2015 Feb 6;10(2):e0116256.
doi: 10.1371/journal.pone.0116256. eCollection 2015.

Effects of exercise and milk fat globule membrane (MFGM) supplementation on body composition, physical function, and hematological parameters in community-dwelling frail Japanese women: a randomized double blind, placebo-controlled, follow-up trial

Hunkyung Kim  1 , Takao Suzuki  2 , Miji Kim  1 , Narumi Kojima  1 , Noriyasu Ota  3 , Akira Shimotoyodome  3 , Tadashi Hase  3 , Erika Hosoi  1 , Hideyo Yoshida  1
Affiliations
Randomized Controlled Trial

Effects of exercise and milk fat globule membrane (MFGM) supplementation on body composition, physical function, and hematological parameters in community-dwelling frail Japanese women: a randomized double blind, placebo-controlled, follow-up trial

Hunkyung Kim et al. PLoS One. .

Abstract

Objective: To investigate the combined and separate effects of exercise and milk fat globule membrane (MFGM) supplementation on frailty, physical function, physical activity level, and hematological parameters in community-dwelling elderly Japanese women.

Methods: A total of 131 frail, elderly women over 75 years were randomly assigned to one of four groups: exercise and MFGM supplementation (Ex+MFGM), exercise and placebo (Ex+Plac), MFGM supplementation, or the placebo group. The exercise group attended a 60-minute training program twice a week for three months, and the MFGM group ingested 1g of the MFGM supplement in pill form, daily for 3 months. The primary outcome measure was change in frailty status based on Fried's frailty phenotype. Secondary outcome measures included body composition, physical function and hematological parameters, and interview survey components assessing lifestyle factors. Participants were followed for 4 months post-intervention.

Results: Significant group × time interactions were observed for usual walking speed (P = 0.005), timed up & go (P<0.001), and insulin-like growth factor-binding protein 3/insulin-like growth factor 1 ratio (P = 0.013). The frailty components revealed that weight loss, exhaustion, low physical activity, and slow walking speed were reversed, but low muscle strength did not significantly changed. Frailty reversal rate was significantly higher in the Ex+MFGM (57.6%) than in the MFGM (28.1%) or placebo (30.3%) groups at post-intervention (χ2 = 8.827, P = 0.032), and at the follow-up was also significantly greater in the Ex+MFGM (45.5%) and Ex+Plac (39.4%) groups compared with the placebo (15.2%) group (χ2 = 8.607, P = 0.035). The exercise+MFGM group had the highest odds ratio (OR) for frailty reversal at post-intervention and follow-up (OR = 3.12, 95% confidence interval (CI) = 1.13-8.60; and OR = 4.67, 95% CI = 1.45-15.08, respectively).

Conclusion: This study suggests that interventions including exercise and nutrition can improve frailty status. Statistically significant additive effects of MFGM with exercise could not be confirmed in this population, and further investigation in larger samples is necessary.

Trial registration: The Japan Medical Association Clinical Trial Registry (JMACCT)JMA-IIA00069.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have the following interests: Co-authors Noriyasu Ota, Akira Shimotoyodome and Tadashi Hase are employed by Kao Corporation. Kao Corporation provided the MFGM supplementation, and the authors included in this publication affiliated with the Biological Science Laboratories of Kao Corporation analyzed the blood samples. The terms of this arrangement have been reviewed and approved by the Tokyo Metropolitan Institute of Gerontology in accordance with its policy on objectivity in research. There are no patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.

Figures

Fig 1
Fig 1. Flow chart of participant recruitment during the randomized controlled trial of exercise and/or nutrition supplementation.
Fig 2
Fig 2. Changes of frailty score between baseline, post-intervention and follow-up.
ANOVA = analysis of variance.
Fig 3
Fig 3. Reversal rates of frailty.
Black bar signifies baseline to post-intervention and gray bar signifies baseline and follow-up. Ex = exercise; MFGM = milk fat globule membrane; P = placebo.
See this image and copyright information in PMC

References

    1. Collard RM, Boter H, Schoevers RA, Oude Voshaar RC (2012) Prevalence of frailty in community-dwelling older persons: a systematic review. Journal of the American Geriatrics Society 60: 1487–1492. 10.1111/j.1532-5415.2012.04054.x - DOI - PubMed
    1. Raji MA, Al Snih S, Ostir GV, Markides KS, Ottenbacher KJ (2010) Cognitive status and future risk of frailty in older Mexican Americans. Journals of Gerontology Series A, Biological Sciences and Medical Sciences 65: 1228–1234. 10.1093/gerona/glq121 - DOI - PMC - PubMed
    1. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, et al. (2001) Frailty in older adults: evidence for a phenotype. Journals of Gerontology Series A, Biological Sciences and Medical Sciences 56: M146–156. - PubMed
    1. Woods NF, LaCroix AZ, Gray SL, Aragaki A, Cochrane BB, et al. (2005) Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study. Journal of the American Geriatrics Society 53: 1321–1330. - PubMed
    1. Theou O, Stathokostas L, Roland KP, Jakobi JM, Patterson C, et al. (2011) The effectiveness of exercise interventions for the management of frailty: a systematic review. J Aging Res 2011: 569194 10.4061/2011/569194 - DOI - PMC - PubMed

Publication types